NO911999L - Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp. - Google Patents

Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp.

Info

Publication number
NO911999L
NO911999L NO91911999A NO911999A NO911999L NO 911999 L NO911999 L NO 911999L NO 91911999 A NO91911999 A NO 91911999A NO 911999 A NO911999 A NO 911999A NO 911999 L NO911999 L NO 911999L
Authority
NO
Norway
Prior art keywords
hydroxythylamines
sopp
exoenzymes
application
potential inhibitors
Prior art date
Application number
NO91911999A
Other languages
English (en)
Other versions
NO911999D0 (no
Inventor
Hariolf Kottmann
Heinz Haenel
Reinhard Kirsch
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO911999D0 publication Critical patent/NO911999D0/no
Publication of NO911999L publication Critical patent/NO911999L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NO91911999A 1990-05-26 1991-05-24 Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp. NO911999L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4017019A DE4017019A1 (de) 1990-05-26 1990-05-26 Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen

Publications (2)

Publication Number Publication Date
NO911999D0 NO911999D0 (no) 1991-05-24
NO911999L true NO911999L (no) 1991-11-27

Family

ID=6407266

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91911999A NO911999L (no) 1990-05-26 1991-05-24 Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp.

Country Status (11)

Country Link
EP (1) EP0459298A3 (no)
JP (1) JPH04235125A (no)
KR (1) KR910019611A (no)
AU (1) AU639785B2 (no)
CA (1) CA2043216A1 (no)
CS (1) CS157091A3 (no)
DE (1) DE4017019A1 (no)
HU (1) HUT61660A (no)
IE (1) IE911787A1 (no)
IL (1) IL98261A0 (no)
NO (1) NO911999L (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482964A (en) * 1994-10-11 1996-01-09 Warner-Lambert Company Substituted phenoxyhydroxypropyl amines as central nervous system agents
SG99290A1 (en) * 1996-04-09 2003-10-27 Nps Pharma Inc Calcilytic compounds
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
UY24949A1 (es) 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos
WO2005080320A1 (en) 2004-02-13 2005-09-01 Warner-Lambert Company Llc Androgen receptor modulators
JP2007533726A (ja) 2004-04-22 2007-11-22 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲンモジュレーター
BRPI0513020A (pt) 2004-07-08 2008-04-22 Warner Lambert Co moduladores de andrÈgenio, seus usos, composição farmacêutica, formulação farmacêutica tópica e artigo de fabricação
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
AU2017340403B2 (en) 2016-10-05 2022-03-17 The United States as Represented by the Department of Veterans Affairs Small molecule AMPK activators
JP7174700B2 (ja) * 2016-12-09 2022-11-17 セルタクシー、エルエルシー ロイコトリエンａ４ヒドロラーゼの阻害剤としてのモノアミン及びモノアミン誘導体
CN115536537B (zh) * 2022-09-21 2023-09-22 华中农业大学 普萘洛尔衍生物及其在抑制植物病原菌中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189481A (en) * 1975-11-18 1980-02-19 Michigan State University Antimicrobial compositions
DE3779352D1 (de) * 1986-04-18 1992-07-02 Hoechst Ag 1-hydroxy-2-pyridone, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten, sowie bei der herstellung der 1-hydroxy-2-pyridone gebildete zwischenprodukte.
IL89997A0 (en) * 1988-04-25 1989-12-15 Lilly Co Eli Propanamine derivatives

Also Published As

Publication number Publication date
CS157091A3 (en) 1992-02-19
DE4017019A1 (de) 1991-11-28
KR910019611A (ko) 1991-12-19
NO911999D0 (no) 1991-05-24
HU911750D0 (en) 1991-12-30
IL98261A0 (en) 1992-06-21
EP0459298A2 (de) 1991-12-04
CA2043216A1 (en) 1991-11-27
HUT61660A (en) 1993-03-01
AU7728691A (en) 1991-11-28
JPH04235125A (ja) 1992-08-24
IE911787A1 (en) 1991-12-04
EP0459298A3 (en) 1993-03-24
AU639785B2 (en) 1993-08-05

Similar Documents

Publication Publication Date Title
NO922683L (no) Fremgangsmaate for hydrogenering av glyserol
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
DK187691A (da) Fremgangsmaade til nyttiggoerelse af affaldsgods
DE69621021D1 (de) Inhibitoren der plättchenaggregation
IT8422567A0 (it) Fissatore dinamico esterno eprocedimento di impiego.
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE59407621D1 (de) Strukturierte Oberflächen von Strömungsmaschinenbauteilen
DE68904083D1 (de) Hmg-coa-reduktaseinhibitoren.
DK0593294T3 (da) Aminderivater som korrosionsinhibitorer
NO911999L (no) Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp.
NO931055D0 (no) Etaloner med spredende belegg
MX9203505A (es) N-aril-n-(4-(1-alquilheterociclico)-piperidinil) amidas y composicines farmaceuticas y metodos que emplean dichos compuestos.
FI1270U1 (fi) Strut foer uppsamling av avfoering
DE69330826D1 (de) Ozonfreundliche korrekturflüssigkeit
DK0650652T3 (da) Fremgangsmåde til implementering af kobling i tids- eller rumdomænet
ITMI910331A1 (it) Applicatore di liquido
DK0642506T3 (da) Heterocyclisk disubstituerede sulfonaminocarbonylforbindelser
DE59101976D1 (de) Lagerung von Ausgleichsmassen.
DE69114489D1 (de) Auftragsgerät zum Auftragen einer beliebigen Flüssigkeit.
ITMI910468A0 (it) Applicatore di liquido
DE69225990D1 (de) Lichtempfindliche Bistrihalomethyl-s-triazin-Verbindung und photopolymerisierbare Zusammensetzung, dieselbe enthaltend
DE69209520D1 (de) Anordnung von halbleiterlasern.
DE69131228D1 (de) Doppelebenenablauffolgeplanung von prozessen
DE69205983D1 (de) Beschichtung von substraten.
NO905003D0 (no) Fremgangsmaate for fremstilling av proteaseinhibitorer frapotetsaft.